Bristol-Myers Squibb Co. BMY
$65.31
+0.69%
at last close
Financials (TTM)
- Revenue
- $49.19 billion
- Net Income
- $9.27 billion
- Net Margin
- 18.85%
- Return on Equity
- 41.55%
- Debt-to-Equity
- 1.92
- P/E Ratio
- 14.39
- Price / Book
- 5.98
- Price / Sales
- 2.71
Over the trailing twelve months, Bristol-Myers Squibb Co. generated revenue of $49.19 billion and net income of $9.27 billion, a net margin of 18.85%.
At the last closing price of $65.31, BMY trades at 14.39 times trailing earnings and 2.71 times sales, with a market capitalization of $133.41 billion.
Key Stats
- Last Close
- $65.31
- Market Cap
- $133.41 billion
- 52-Week Range
- $42.52 – $65.66
- Average Volume
- 12.82 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
